Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605543666 | ||
| 003 | CHVBK | ||
| 005 | 20210128100927.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150401xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s00109-014-1228-0 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s00109-014-1228-0 | ||
| 245 | 0 | 0 | |a Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc |h [Elektronische Daten] |c [Yaxi Ma, Handi Cao, Siyue Lou, Xuejing Shao, Wen Lv, Xiaotian Qi, Yujia Liu, Meidan Ying, Qiaojun He, Xiaochun Yang] |
| 540 | |a Springer-Verlag Berlin Heidelberg, 2014 | ||
| 690 | 7 | |a Aurora B |2 nationallicence | |
| 690 | 7 | |a c-Myc |2 nationallicence | |
| 690 | 7 | |a Cisplatin |2 nationallicence | |
| 690 | 7 | |a Chemotherapy resistance |2 nationallicence | |
| 690 | 7 | |a Ovarian carcinoma |2 nationallicence | |
| 690 | 7 | |a Drug in combination |2 nationallicence | |
| 700 | 1 | |a Ma |D Yaxi |u Department of Gynecology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 310009, Hangzhou, China |4 aut | |
| 700 | 1 | |a Cao |D Handi |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 700 | 1 | |a Lou |D Siyue |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 700 | 1 | |a Shao |D Xuejing |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 700 | 1 | |a Lv |D Wen |u Tongde Hospital of Zhejiang Province, 310009, Hangzhou, China |4 aut | |
| 700 | 1 | |a Qi |D Xiaotian |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 700 | 1 | |a Liu |D Yujia |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 700 | 1 | |a Ying |D Meidan |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 700 | 1 | |a He |D Qiaojun |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 700 | 1 | |a Yang |D Xiaochun |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | |
| 773 | 0 | |t Journal of Molecular Medicine |d Springer Berlin Heidelberg |g 93/4(2015-04-01), 427-438 |x 0946-2716 |q 93:4<427 |1 2015 |2 93 |o 109 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00109-014-1228-0 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s00109-014-1228-0 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Ma |D Yaxi |u Department of Gynecology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 310009, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Cao |D Handi |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Lou |D Siyue |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Shao |D Xuejing |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Lv |D Wen |u Tongde Hospital of Zhejiang Province, 310009, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Qi |D Xiaotian |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Liu |D Yujia |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Ying |D Meidan |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a He |D Qiaojun |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yang |D Xiaochun |u Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Journal of Molecular Medicine |d Springer Berlin Heidelberg |g 93/4(2015-04-01), 427-438 |x 0946-2716 |q 93:4<427 |1 2015 |2 93 |o 109 | ||